GenMark Diagnostics to Participate in Upcoming Investor Conferences

Rhea-AI Summary

GenMark Diagnostics (NASDAQ: GNMK) announced its participation in two upcoming investor conferences. Management will present at the William Blair 40th Annual Growth Stock Conference on June 10, 2020, at 12:20 a.m. ET, accessible via webcast at ir.genmarkdx.com. Additionally, GenMark will host virtual one-on-one meetings at the Raymond James Human Health Innovations Conference on June 16, 2020. GenMark specializes in multiplex molecular diagnostic solutions aimed at improving patient care and reducing healthcare costs.

CARLSBAD, Calif., May 27, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) (“GenMark” or the “Company”), a molecular diagnostics company focused on developing and commercializing multiplex molecular diagnostic solutions designed to enhance patient care, improve key quality metrics, and reduce the total cost-of-care, today announced that the company plans to participate in two upcoming investor conferences.

GenMark’s management is scheduled to present at the William Blair 40^th Annual Growth Stock Conference in a virtual setting on Wednesday, June 10^th, 2020 at 12:20 a.m. ET. Interested parties can access the live and archived webcast at ir.genmarkdx.com.

GenMark’s management team will also be hosting virtual one-on-one meetings at the Raymond James Human Health Innovations Conference on Tuesday, June 16, 2020. Interested parties can contact their representative at Raymond James for additional information.

ABOUT GENMARK

GenMark is a leading provider of multiplex molecular diagnostic solutions designed to enhance patient care, improve key quality metrics, and reduce the total cost-of-care. Utilizing GenMark's proprietary eSensor^® detection technology, GenMark's eSensor XT-8^® and ePlex^® systems are designed to support a broad range of molecular diagnostic tests with compact, easy-to-use workstations and self-contained, disposable test cartridges. GenMark’s ePlex: The True Sample-to-Answer Solution™ is designed to optimize laboratory efficiency and address a broad range of infectious disease testing needs, including respiratory, bloodstream, and gastrointestinal infections. For more information, visit www.genmarkdx.com.

Investor Relations Contact
Leigh Salvo
(415) 937-5404
ir@genmarkdx.com

FAQ

What conferences is GenMark Diagnostics attending in June 2020?

GenMark Diagnostics is participating in the William Blair 40th Annual Growth Stock Conference on June 10 and the Raymond James Human Health Innovations Conference on June 16, 2020.

What is the date and time of GenMark's presentation at the William Blair conference?

GenMark's presentation at the William Blair conference is scheduled for June 10, 2020, at 12:20 a.m. ET.

How can I access GenMark's presentation at the William Blair conference?

GenMark's presentation can be accessed live and archived at ir.genmarkdx.com.

Who can I contact for additional information about GenMark's virtual one-on-one meetings?

For more information about GenMark's virtual one-on-one meetings at the Raymond James conference, please contact their representative at Raymond James.

What is GenMark Diagnostics known for?

GenMark Diagnostics is known for providing multiplex molecular diagnostic solutions designed to enhance patient care and reduce the total cost-of-care.